Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C

Canadian Journal of Gastroenterology

Volumn 11, Issue 4, 1997, Pages 294-297

  Anderson, Frank H ^a,b   Zeng, Lecheng ^a   Yoshid, Eric M ^a   Rock, Natalie R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Combination therapy; Hepatitis C; Interferon; Keto profen

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE;

EID: 0030993079     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/562402     Document Type: Article

References (14)

1. CASL Hepatitis Consensus Group. Treatment of chronic viral hepatitis with alpha-interferon: a consensus conference report. Can J Gastroenterol 1994;8:179-84.
2. Poynard T, Bedossa P, Chevallier M, et al. A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995;332:1457-62.
3. Terrault N, Feinman SV. Interferons for viral hepatitis. Transfus Med Rev 1995;IX:29-52.
4. Brillanti S, Garson J, Foli M, et al. A pilot study of combination therapy with ribavirin plus interferon alpha for interferon alpha-resistant chronic hepatitis C. Gastroenterology 1994;107:812-7.
5. Angelico M, Gandin C, Pescarmona E, et al. Recombination interferon-α and ursodeoxycholic acid versus interferon-α alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term followup. Am J Gastroenterol 1995;90:263-9.
6. Hannigan DE, Williams BRG. Signal transduction by interferon-α through arachidonic acid metabolism. Science 1991;251:204-7.
7. Andreone P, Cursaro C, Gramenzi A, et al. Indomethacin enhances serum 2′5′-oligoadenylate synthetase synthesis in patients with hepatitis B and C virus chronic active hepatitis. J Hepatol 1994;21:984-8.
8. Andreone P, Cursaro C, Gramenzi A, et al. Pilot study of α-interferon and ketoprofen combined therapy in non-responder patients with chronic hepatitis C: an interim report. Gastroenterology 1994;106:A859. (Abst)
9. Andreone P, Gramenzi A, Cursaro C, et al. A pilot study of IFNαketoprofen or IFNα+ribavirin in patients with HCV chronic active hepatitis (CAH) non-responders (NR) to IFNA alone. Gastroenterology 1996;110:A1143. (Abst)
10. Caldwell SH, Dickson RC, Driscoll C, Sue M, Yeaton P. A pilot study using piroxicam with Interferon α2b in the retreatment of refractory hepatitis C. Gastroenterology 1995;108:A1043. (Abst)
11. Okamoto H, Okada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990;60:215-22.
12. Goodman ZD, Ishak KG. Histopathology of hepatitis C infection. Semin Liver Dis 1995;15:70-81.
13. Cathcart BJ, Vince JD, Gordon AJ, Bell MA, Chalmers IM. Studies on 2-(3-benzoylphenyl propionic acid (Orudis). A double-blind crossover trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes. Ann Rheum Dis 1973;32:62-5.
14. Jouet P, Roudot-Thoraval F, Dhumeaux D, Metreau JM, Le Groupe Francais pour l'étude du traitement des hépatites chroniques NANB/C. Comparative efficacy of interferon alpha in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology 1994;106:686-90.